This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.08% per year. These returns cover a period from January 1, 1988 through May 6, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Keurig Dr Pepper (KDP) Q1 Earnings Beat, Soft Sales Hurt Stock
by Zacks Equity Research
Keurig Dr Pepper (KDP) reports strong Q1 earnings, backed by higher operating income and reduced debt. However, effects of changes in the Allied Brands portfolio and a calendar shift mar the top line.
New Age Beverages (NBEV) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
New Age Beverages (NBEV) first-quarter 2019 results are likely to benefit from brand strength and the Morinda buyout.
Why Earnings Season Could Be Great for Keurig Dr Pepper (KDP)
by Zacks Equity Research
Keurig Dr Pepper (KDP) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Factors Likely to Shape Keurig Dr Pepper (KDP) Q1 Earnings
by Zacks Equity Research
Keurig Dr Pepper (KDP) witnesses softness at its Coffee Systems business, which might hurt its first-quarter 2019 results. However, it is gaining from the merged benefits and robust volume/mix.
Keurig Dr Pepper (KDP) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Keurig Dr Pepper (KDP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Monster Beverage (MNST) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
Monster Beverage's (MNST) robust trends in the energy drinks category might boost sales and earnings in first-quarter 2019. However, concerns regarding higher input and freight costs remain.
Will Lower Core Sales Hurt Newell's (NWL) Earnings in Q1?
by Zacks Equity Research
Newell (NWL) witnesses decline in core sales, which might hurt overall sales in first-quarter 2019.
Can AB InBev (BUD) Return to Earnings Beat Trend Amid Woes?
by Zacks Equity Research
AB InBev's (BUD) first-quarter 2019 earnings may continue to struggle due to soft trend of beer sales in the United States. However, its premiumization efforts and global brands' strength bode well.
Molson Coors (TAP) to Post Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Molson Coors (TAP) to gain from improved pricing, International strength and cost savings in first-quarter 2019. Soft North America volume, input cost inflation and currency headwinds may persist.
Factors Likely to Decide Avon's (AVP) Fate in Q1 Earnings
by Zacks Equity Research
Soft Representatives growth and currency headwind are likely to mar Avon's (AVP) Q1 results. However, the Open Up Avon strategy may bring some respite.
Can Clorox (CLX) Keep the Earnings Beat Streak Alive in Q3?
by Zacks Equity Research
Clorox (CLX) gains from smooth progress on its 2020 Strategy, focus on e-commerce growth and brand-management initiatives.
Here's Why Archer Daniels' (ADM) Q1 Earnings May Decline Y/Y
by Zacks Equity Research
Archer Daniels (ADM) witnesses softness in its Carbohydrate Solutions segment, which is likely to weigh on its first-quarter 2019 results. However, its cost-saving efforts are encouraging.
5 Consumer Staples Stocks Set to Beat This Earnings Season
by Zacks Equity Research
Although high input costs are a concern for players in the consumer staples sector, a few are likely to gain from prudent acquisitions, savings and brand augmenting efforts.
Why Is Keurig Dr Pepper (KDP) Up 11.2% Since Last Earnings Report?
by Zacks Equity Research
Keurig Dr Pepper (KDP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
3 Reasons to Add Monster Beverage (MNST) to Your Portfolio
by Zacks Equity Research
Monster Beverage (MNST) is well poised for growth, driven by momentum in the energy drinks business and strong international presence.
Here's What You Must Know About Keurig Dr Pepper (KDP) Stock
by Zacks Equity Research
Keurig Dr Pepper's (KDP) growth strategies like acquisitions and partnerships position it for long-term growth. However, softness in the Coffee Systems business remains a hurdle.
The Zacks Analyst Blog Highlights: NextEra, T-Mobile, Petrobras, Keurig Dr Pepper and United Continental
by Zacks Equity Research
The Zacks Analyst Blog Highlights: NextEra, T-Mobile, Petrobras, Keurig Dr Pepper and United Continental
Top Stock Reports for NextEra Energy, T-Mobile & Petrobras
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including NextEra Energy (NEE), T-Mobile (TMUS) and Petrobras (PBR).
Soft Drinks Outlook: Can Portfolio Shift Bring Back the Fizz?
by Zacks Equity Research
The soft drinks space continues to struggle due to higher costs and soft carbonated-drinks sales. Meanwhile, companies' efforts to skew their portfolio toward health drinks and juices should help.
Keurig (KDP) Q4 Earnings In Line, Stock Slips on Soft View
by Zacks Equity Research
Keurig Dr Pepper (KDP) posts mixed fourth-quarter 2018 results, with sales missing estimates and earnings in line. A lower-than-expected earnings view for 2019 hurts investor sentiment.
Keurig Dr Pepper (KDP) to Post Q4 Earnings: What's in Store?
by Zacks Equity Research
Keurig Dr Pepper (KDP) gains from integration of the merged companies, which is aiding quarterly performance. However, lower realized prices, unfavorable currency and higher costs remain bottlenecks.
Earnings Preview: Keurig Dr Pepper (KDP) Q4 Earnings Expected to Decline
by Zacks Equity Research
Keurig Dr Pepper (KDP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Zacks Analyst Blog Highlights: Morgan Stanley, Intuitive Surgical, Colgate-Palmolive, Keurig Dr Pepper and Prudential Financial
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Morgan Stanley, Intuitive Surgical, Colgate-Palmolive, Keurig Dr Pepper and Prudential Financial
Top Research Reports for Morgan Stanley, Intuitive Surgical & Colgate-Palmolive
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, Morgan Stanley (MS), Intuitive Surgical, Inc. (ISRG) and Colgate-Palmolive Company (CL).
Will P&G's (PG) Efforts Help Sustain Stock Momentum in 2019?
by Zacks Equity Research
Procter & Gamble (PG) displays momentum, backed by impressive growth strategies and cost-saving efforts to boost margins, which have boosted its top and bottom lines.